Welcome to Edinburgh Biosciences
Redefining the future of cataract care.
A new light-based approach is coming.
At Edinburgh Biosciences, we are advancing a breakthrough in how cataract-related vision changes may be managed in everyday eye-care settings. Our technology, Revisyon™, Powered by Photon Protein Modulation is designed to bring a completely new option into the cataract pathway — non-invasive, accessible, and delivered close to home.
Revisyon™ is moving through final stages of development, with UK introduction planned from 2026.
The future of cataract care is closer than you think.
Transforming the cataract journey
For decades, cataract care has relied on a single pathway.
We believe it doesn’t have to stay that way.
Edinburgh Biosciences is pioneering a new approach using the power of light. Our mission is simple:
to give patients and clinicians more choice, earlier intervention, and a more personalised pathway.
Revisyon™ has been shaped with input from scientists, optometrists, and ophthalmologists, and is now progressing toward real-world clinical use.
A new era in eye care is beginning — and it starts here.
Revisyon™ — A new light-based approach to cataract-related vision changes
Revisyon™ is an innovative, non-invasive technology designed to fit seamlessly into primary eye care. It brings advanced treatment with Photon Protein Modulation with light-based lens optimisation.
Engineered around precision, comfort, and convenience, Revisyon™ aims to support people experiencing early vision changes — long before daily life is affected.
Why a new option is needed
Cataracts affect millions worldwide and are becoming more common as people live longer. Today, surgery remains the only established treatment, often accessed only once vision has significantly deteriorated.
But what if support could begin earlier?
What if eye-care professionals had a new tool — one that fits easily into the community setting?
Revisyon™ is being developed to create that possibility.
Harnessing the power of light
Revisyon™ brings advanced light-based technology to support clearer vision through a gentle, non-invasive in-clinic experience.
The technology has been designed to work with the eye’s natural structures, using precisely controlled light exposure to optimise lens clarity.
As we progress toward launch, more details will be revealed — including patient results, professional protocols, and clinical pathways.
A new chapter for eye care is almost here.
Empowering primary eye care
Revisyon™ is being designed with Optometrists and Ophthalmologists at its core:
- Delivered in-clinic
- Non-invasive
- Fully guided workflow
- Rapid appointment times
- Integrated treatment
As we prepare for UK availability, we are working closely with selected practices to shape training, patient selection, and clinical pathways.
Be among the first to bring this innovation to your patients.
Clinical Status
Revisyon™ is progressing through final evaluation and pre-launch activity ahead of an expected UK introduction very soon.
Early interest from eye-care professionals is strong, and we are now opening expressions of interest for clinics wishing to be part of the first wave.
